This is a Validated Antibody Database (VAD) review about cow receptor for advanced glycosylation end products, based on 5 published articles (read how Labome selects the articles), using receptor for advanced glycosylation end products antibody in all methods. It is aimed to help Labome visitors find the most suited receptor for advanced glycosylation end products antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
receptor for advanced glycosylation end products synonym: RAGE; advanced glycosylation end product-specific receptor; receptor for advanced glycosylation end products
Abcam
| rabbit polyclonal |
| Abcam receptor for advanced glycosylation end products antibody (Abcam, ab37647) was used in western blot on human samples at 1:1000 (fig 2a). Oncotarget (2016) ncbi |
| rabbit polyclonal |
| In order to study the paracrine effects of S100A4 and receptor for advanced glycation end products on melanoma metastasis, Abcam receptor for advanced glycosylation end products antibody (abcam, ab37647) was used in western blot on human samples (fig 1a). Biochem Biophys Res Commun (2016) ncbi |
| rabbit polyclonal |
| Abcam receptor for advanced glycosylation end products antibody (Abcam, ab37647) was used in western blot on human samples (fig 1). Oncotarget (2015) ncbi |
| rabbit polyclonal |
| Abcam receptor for advanced glycosylation end products antibody (Abcam, ab37647) was used in western blot on rat samples at 1:1000. PLoS ONE (2013) ncbi |
| rabbit polyclonal |
| Abcam receptor for advanced glycosylation end products antibody (Abcam, ab37647) was used in blocking or activating experiments on human samples . PLoS ONE (2013) ncbi |
Articles Reviewed
- Wang J, Ma L, Tang X, Zhang X, Qiao Y, Shi Y, et al. Doxorubicin induces apoptosis by targeting Madcam1 and AKT and inhibiting protein translation initiation in hepatocellular carcinoma cells. Oncotarget. 2015;6:24075-91 pubmed
contribute
- If you are aware of any publication with knockout studies validating a monoclonal or recombinant antibody, either purchased from a supplier or developed by the author(s), please notify us through feedback.
questions and comments
